Command Palette

Search for a command to run...

LINCOLN
525.1(-0.71%)
1W: -0.63%

Lincoln Pharmaceuticals Quarterly Results

Charts

YoY Net Sales (Quarterly)
Operating Margin
EPS Growth

Pros & Cons

POSITIVES
  • Revenue growth of 10% in the latest quarter shows strong demand.
  • Net profit increased significantly by 26% compared to last quarter.
  • Operating profit margins improved, indicating better cost management.
NEGATIVES
  • Profit before tax decreased by 12% from the previous quarter.
  • Material costs rose, impacting overall profitability.
  • Tax percentage increased, reducing net profit margins.

Quarterly Results Data (Numbers are in Crore)

FieldTrendJun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Jun 25
Revenue
135.62155.99146.45142.49147.28161.21146.55154.07
Expenses
117.86127.81119.76127.30128.21136.41126.84133.95
Operating Profit
17.7628.1726.6915.2019.0724.8119.7120.12
Other Income
7.698.7011.027.0210.419.988.9715.27
Interest
0.420.390.150.500.440.350.730.21
Depreciation
2.542.582.812.693.223.223.223.48
Profit Before Tax
25.4536.8737.7122.2229.4834.7828.6835.39
Tax
6.439.219.673.625.818.457.917.71
Net Profit
19.0127.6528.0418.6023.6726.3320.7727.68
Eps in Rs
9.4913.81149.2811.8213.1510.3713.82

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.